insights_auto
Why is BOT up २५.००%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.०१०
arrow_upward
+२५.००%(+०.००२०) 1D
नोभेम्बर १७, १६:१०:०६ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.२१ करोड
Avg. vol.
१.०९ करोड
Volume
१.०३ करोड
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.२१ करोड
Avg. vol.
१.०९ करोड
Volume
१.०३ करोड
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
TradingView
·
१ घण्टा पहिले
Dow Plunges 700 Points as S&P 500 and Nasdaq Fall Ahead of Nvidia Earnings
BigGo Finance
·
२ घण्टा पहिले
Netflix Shares Trade Below S&P 500 Multiple After 35% Slide as Analysts See Upside
ChartMill
·
१ घण्टा पहिले
Today's S&P 500 Top Movers: Reddit Leads Gainers, Salesforce Leads Decliners
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd